Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: Evidence from a 12-month longitudinal study

Psychopharmacology

Volumn 200, Issue 3, 2008, Pages 425-437

  De Sola, Susana ^a,b   Tarancón, Thais ^b,c   Peña Casanova, Jordi ^a,b   Espadaler, Josep María ^b,c   Langohr, Klaus ^b,e   Poudevida, Sandra ^b   Farré, Magí ^a,b   Verdejo García, Antonio ^b,f   De La Torre, Rafael ^b,d  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^f UNIVERSITY OF GRANADA   (Spain)

Author keywords

Cannabis; Cognitive impairment; Ecstasy; ERP; Event related potentials; MDMA; P300

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; ILLICIT DRUG; RECREATIONAL DRUG; SEROTONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EVOKED AUDITORY RESPONSE; FOLLOW UP; HUMAN; LATENT PERIOD; LONGITUDINAL STUDY; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MULTIPLE DRUG ABUSE; NEUROTOXICITY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; VERBAL BEHAVIOR;

ADULT; AMPHETAMINE-RELATED DISORDERS; ATTENTION; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MENTAL RECALL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; PROBLEM SOLVING; PSYCHOMOTOR PERFORMANCE; REACTION TIME; RECOGNITION (PSYCHOLOGY); SEROTONIN AGENTS; VERBAL BEHAVIOR; VERBAL LEARNING; WECHSLER SCALES; YOUNG ADULT;

EID: 51849104660     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1217-5     Document Type: Article

References (64)

1. JV Baldo S Schwartz D Wilkins NF Dronkers 2006 Role of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mapping J Int Neuropsychol Soc 12 896 900
2. Benton AL, Hamsher K deS (1976) Multilingual Aphasia Examination: Manual of instruction. Iowa City: University of Iowa
3. C Casco M Forcella G Beretta A Grieco G Campana 2005 Long-term effects of MDMA (ecstasy) on the human central nervous system revealed by visual evoked potentials Addict Biol 10 187 195
4. RJ Croft A Klugman T Baldeweg JG Gruzelier 2001 Electrophysiological evidence of serotonergic impairment in long-term MDMA ("Ecstasy") users Am J Psychiatr 158 1687 1692
5. RJ Croft AJ Mackay AT Mills JG Gruzelier 2001 The relative contributions of ecstasy and cannabis to cognitive impairment Psychopharmacology 153 373 379
6. J Daumann B Till T Fischermann M Rezk E Gouzoulis-Mayfrank 2006 Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study J Psychopharmacol 20 236 244
7. R de la Torre M Farre 2004 Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans Trends Pharmacol Sci 25 505 508
8. Delis DC, Kramer JH, Kaplan E, Ober BA (2000) California Verbal Learning Test-Second Edition (CVLT-II). San Antonio: Psychological Corporation
9. European Monitoring Centre for Drugs and Drug Addiction (2007) OEDT Annual Report- The State of the Drugs Problem in Europe, pp. 48-55
10. HC Fox A McLean JJ Turner AC Parrott R Rogers BJ Sahakian 2002 Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users Psychopharmacology 162 203 214
11. A Gamma D Brandeis R Brandeis FX Vollenweider 2005 The P3 in 'ecstasy' polydrug users during response inhibition and execution J Psychopharmacol 19 504 512
12. E Gouzoulis-Mayfrank J Daumann 2006 Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? Addiction 101 348 361
13. E Gouzoulis-Mayfrank T Fischermann M Rezk B Thimm G Hensen J Daumann 2005 Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use Drug Alcohol Depend 78 317 323
14. AR Green AO Mechan JM Elliott E O'Shea MI Colado 2003 The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") Pharmacol Rev 55 463 508
15. JE Fisk C Montgomery M Wareing PN Murphy 2005 Reasoning deficits in ecstasy (MDMA) polydrug users Psychopharmacology 181 550 559
16. NK Hansell MJ Wright M Luciano GM Geffen LB Geffen NG Martin 2005 Genetic covariation between event-related potential (ERP) and behavioral non-ERP measures of working-memory, processing speed, and IQ Behav Genet 35 695 706
17. M Hansenne 2000 The p300 cognitive event-related potential. I. theoretical and psychobiologic perspectives Neurophysiol Clin 30 191 210
18. G Hatzidimitriou UD McCann GA Ricaurte 1999 Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4- methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery J Neurosci 19 5096 5107
19. H Horn N Syed H Lanfermann K Maurer T Dierks 2003 Cerebral networks linked to the event-related potential P300 Eur Arch Psychiatry Clin Neurosci 253 154 159
20. Hothorn T, Bretz F, Westfall P with contributions by Richard M. Heiberger (2007) multcomp: simultaneous inference for general linear hypotheses. R package version 0.992-6.
21. WG Iacono M McGue 2006 Association between P3 event-related brain potential amplitude and adolescent problem behavior Psychophysiology 43 465 469
22. WG Iacono SR Carlson SM Malone M McGue 2002 P3 event-related potential amplitude and the risk for disinhibitory disorders in adolescent boys Arch Gen Psychiatry 59 750 757
23. AD Kalechstein R De La Garza 2nd JJ Mahoney 3rd WE Fantegrossi TF Newton 2007 MDMA use and neurocognition: a meta-analytic review Psychopharmacology 189 531 537
24. V Knott A Millar L Dulude L Bradford F Alwahhabi T Lau C Shea A Wiens 2004 Event-related potentials in young and elderly adults during a visual spatial working memory task Clin EEG Neurosci 35 185 192
25. CT Lamers A Bechara M Rizzo JG Ramaekers 2006 Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls J Psychopharmacol 20 302 311
26. DE Linden 2005 The p300: where in the brain is it produced and what does it tell us? Neurosci 11 563 576
27. J Lyles JL Cadet 2003 Methylenedioxymethamphetamine (MDMA, ecstasy) neurotoxicity: cellular and molecular mechanisms Brain Res Brain Res Rev 42 155 168
28. UD McCann Z Szabo E Seckin P Rosenblatt WB Mathews HT Ravert RF Dannals GA Ricaurte 2005 Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB Neuropsychopharmacology 30 1741 1750
29. S Mejias M Rossignol D Debatisse E Streel L Servais JM Guerit P Philippot S Campanella 2005 Event-related potentials (ERPs) in ecstasy (MDMA) users during a visual oddball task Biol Psychol 69 333 352
30. Miller EN (1990) California Computerized Assessment Battery (CalCAP): Manual. Los Angeles: Norland Software
31. C Montgomery JE Fisk R Newcombe PN Murphy 2005 The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory Psychopharmacology 182 262 276
32. MJ Morgan 2000 Ecstasy (MDMA): a review of its possible persistent psychological effects Psychopharmacology 152 230 248
33. K Nebel H Wiese P Stude A de Greiff HC Diener M Keidel 2005 On the neural basis of focused and divided attention Brain Res Cogn Brain Res 25 760 776
34. AC Parrott 2006 MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress J Psychopharmacol 20 147 163
35. AC Parrott J Rodgers T Buchanan J Ling T Heffernan AB Scholey 2006 Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users Hum Psychopharmacol 21 285 298
36. AC Parrott RM Milani E Gouzoulis-Mayfrank J Daumann 2007 Cannabis and ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users J Neural Transm 114 959 968
37. S Pichini S Poudevida M Pujadas E Menoyo R Pacifici M Farré R de la Torre 2006 Assessment of chronic exposure to MDMA in a group of consumers by segmental hair analysis Ther Drug Monit 28 106 109
38. Pinheiro J, Bates D, DebRoy S, Sarkar D the R Core team (2007) nlme: linear and nonlinear mixed effects models. R package version 3.1-86
39. J Polich 2007 Updating P300: an integrative theory of P3a and P3b Clin Neurophysiol 118 2128 2148
40. J Polich JR Criado 2006 Neuropsychology and neuropharmacology of P3a and P3b Int J Psychophysiol 60 172 185
41. M Pujadas S Pichini S Poudevida E Menoyo P Zuccaro M Farré R de la Torre 2003 Development and validation of a gas chromatography-mass spectrometry assay for hair analysis of amphetamine, methamphetamine and methylenedioxy derivatives J Chromatogr B Analyt Technol Biomed Life Sci 798 249 255
42. BB Quednow F Jessen KU Kuhn W Maier I Daum M Wagner 2006 Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction J Psychopharmacol 20 373 384
43. AM Ramier H Hécaen 1970 Rôle respectif des atteintes frontales et de la latéralisation lésionnelle dans les déficits de la fluence verbale Revue Neurologique 123 17 22
44. L Reneman T Schilt MM de Win J Booij B Schmand W van den Brink O Bakker 2006 Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users J Psychopharmacol 20 389 399
45. A Rey 1941 Ĺexamen psychologique dans le cas d́encé phalopathie traumatique Archives de Psychologie 28 286 340
46. Rey A (1959) Test de copie et de reproduction de mémoire de figures géométriques complexes. Les éditions du Centre de Psychologie appliqué. Paris
47. J Rodgers T Buchanan AB Scholey TM Heffernan J Ling AC Parrott 2003 Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study J Psychopharmacol 17 389 396
48. M Sala D Braida 2005 Endocannabinoids and 3,4- methylenedioxymethamphetamine (MDMA) interaction Pharmacol Biochem Behav 81 407 416
49. U Scheffel Z Szabo WB Mathews PA Finley RF Dannals HT Ravert K Szabo J Yuan GA Ricaurte 1998 In vivo detection of short- and long-term MDMA neurotoxicity-a positron emission tomography study in the living baboon brain Synapse 29 183 192
50. T Shallice 1982 Specific impairments of planning Philosophical Transactions of the Royal Society of London 298 199 209
51. Smith A (1973) Symbol Digit Modalities Test (SDMT). Manual. Los Angeles: Western Psychological Services
52. N Solowij PT Michie AM Fox 1995 Differential impairments of selective attention due to frequency and duration of cannabis use Biol Psychiatry 37 731 739
53. R Thomasius P Zaplova K Petersen R Buchert B Andresen L Wartberg B Nebeling A Schmoldt 2006 Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective J Psychopharmacol 20 211 225
54. F Tuchtenhagen J Daumann C Norra R Gobbelé S Becker S Pelz H Sass H Buchner E Gouzoulis-Mayfrank 2000 High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users Neuropsychopharmacology 22 608 617
55. United Nations Office on Drugs and Crime (UNODC) (2006) World Drug Report 1:143-152
56. SL Verheyden JA Henry HV Curran 2003 Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users Hum Psychopharmacol 18 507 517
57. TD Wager EE Smith 2003 Neuroimaging studies of working memory: a meta-analysis Cogn Affect Behav Neurosci 3 255 274
58. M Wareing JE Fisk C Montgomery PN Murphy MD Chandler 2007 Information processing speed in ecstasy (MDMA) users Hum Psychopharmacol 22 81 88
59. Wechsler D (1977a) Wechsler Adult Intelligence Scale-III. San Antonio: The Psychological Corporation
60. Wechsler D (1977b) Wechsler Memory Scale. Third edition manual. San Antonio: The Psychological Corporation
61. HH Yoon WG Iacono SM Malone M McGue 2006 Using the brain P300 response to identify novel phenotypes reflecting genetic vulnerability for adolescent substance misuse Addict Behav 31 1067 1087
62. KK Zakzanis DA Young 2001 Memory impairment in abstinent MDMA ("ecstasy") users: a longitudinal investigation Neurology 56 966 969
63. KK Zakzanis Z Campbell 2006 Memory impairment in now abstinent MDMA users and continued users: a longitudinal follow-up Neurology 66 740 741
64. KK Zakzanis Z Campbell D Jovanovski 2007 The neuropsychology of ecstasy (MDMA) use: a quantitative review Hum Psychopharmacol 22 427 435